This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Flowers Foods (FLO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FLOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BitFuFu Inc. (FUFU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FUFUPositive Net Change CANPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Should You Buy, Hold, or Sell Archer Aviation Stock Ahead of Q2 Earnings?
by Aparajita Dutta
Archer Aviation's Q2 outlook brightens with a positive Earnings ESP and new global partnerships, but industry headwinds remain.
BAPositive Net Change ERJPositive Net Change ACHRNegative Net Change
aerospace earnings-preview
Exploring Analyst Estimates for Red Robin (RRGB) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Red Robin (RRGB), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
RRGBNo Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Kamada (KMDA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
KMDAPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q4 Potential of Coherent (COHR): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Coherent (COHR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
COHRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About Cisco (CSCO) Q4 Earnings
by Zacks Equity Research
Besides Wall Street's top-and-bottom-line estimates for Cisco (CSCO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2025.
CSCOPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Bally's (BALY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Bally's (BALY) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
BALYPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Ahead of CAE (CAE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of CAE (CAE) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
CAEPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of Fidelis Insurance (FIHL) Q2 Earnings
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Fidelis Insurance (FIHL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
FIHLPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Countdown to Brinker International (EAT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Brinker International (EAT) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
EATNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With European Wax Center (EWCZ) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of European Wax Center (EWCZ) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
EWCZNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to Globale Online (GLBE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globale Online (GLBE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
GLBENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Wall Street's Insights Into Key Metrics Ahead of MSG Entertainment (MSGE) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of MSG Entertainment (MSGE) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
MSGENegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Is CVS a Smart Buy Now on Strong Q2, Low Valuation & Long-Term Upside?
by Urmimala Biswas
CVS appears well-poised on strong Q2 revenue growth, raised full-year guidance and momentum in key healthcare segments.
UNHPositive Net Change CVSPositive Net Change HLFPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-surprise healthcare medical medical-devices
Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Ontrak (OTRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OTRKPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SABSNegative Net Change ABSINegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Atlanticus Holdings Corporation (ATLC) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Atlanticus (ATLC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATLCPositive Net Change MRXNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Birkenstock (BIRK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Birkenstock (BIRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BIRKNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Dianthus Therapeutics, Inc. (DNTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DNTHNegative Net Change INONegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Globant (GLOB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Globant (GLOB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GLOBNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Life360 (LIF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Life360 (LIF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LIFNegative Net Change SSTIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Piedmont Lithium Inc. - Sponsored ADR (PLL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Piedmont Lithium Inc. - Sponsored ADR (PLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PLLPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Tapestry (TPR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Tapestry (TPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TPRPositive Net Change XELBNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Amcor (AMCR) Reports Next Week: What Awaits?
by Zacks Equity Research
Amcor (AMCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMCRPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate